WBDE(SZ:002082)2024-04-29 11:25Financial Performance - The company's revenue for Q1 2024 was CNY 429,172,675.52, representing an increase of 11.41% compared to CNY 385,228,931.74 in the same period last year[5] - Net profit attributable to shareholders was CNY 28,838,483.33, up 5.49% from CNY 27,336,957.81 year-on-year[5] - The net profit after deducting non-recurring gains and losses decreased by 43.19% to CNY 14,097,320.81 from CNY 24,813,590.56 in the previous year[5] - Total comprehensive income for the current period was ¥26,705,240.33, significantly higher than ¥12,886,270.71 in the previous period[21] - Basic and diluted earnings per share increased to ¥0.0466 from ¥0.0442 in the previous period[21] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to CNY 101,357,363.89, a 192.38% increase from a negative CNY 109,712,047.84 in the same period last year[5] - Cash and cash equivalents at the end of the period were ¥183,656,176.46, down from ¥434,495,094.70 at the end of the previous period[23] - Investment activities resulted in a net cash outflow of ¥164,203,107.37, compared to a net outflow of ¥23,442,078.90 in the previous period[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,406,599,505.53, reflecting a 2.57% increase from CNY 4,296,357,984.94 at the end of the previous year[5] - The total liabilities of the company amounted to approximately RMB 1.62 billion, compared to RMB 1.54 billion at the beginning of the period, representing an increase of about 5.0%[18] - The company's cash and cash equivalents decreased to approximately RMB 192.24 million from RMB 226.61 million, a decline of about 15.1%[17] Shareholder Equity - The company's equity attributable to shareholders increased by 1.15% to CNY 2,688,277,968.03 from CNY 2,657,692,685.28 at the end of the previous year[5] - The company's total equity increased to approximately RMB 2.79 billion from RMB 2.76 billion, reflecting a growth of about 1.4%[19] Operational Metrics - Operating profit for the current period was ¥31,463,880.22, up 30.2% from ¥24,185,412.27 in the previous period[20] - The company reported a decrease in total operating costs to ¥410,431,118.52 from ¥361,442,371.31, reflecting a cost management improvement[20] Other Income and Receivables - Other income surged by 1126.52% to CNY 18,225,729.34, primarily due to an increase in government subsidies[9] - The company reported a significant increase in accounts receivable, which rose by 52.00% to CNY 204,170,100.02, attributed to an increase in bank acceptance bills[9] - The company reported a decrease in other receivables, which fell to approximately RMB 88.99 million from RMB 58.67 million, an increase of about 51.5%[17] Investments and Borrowings - The company’s long-term borrowings decreased by 34.69% to CNY 53,234,653.89, as a result of reclassifying some long-term borrowings to current liabilities[9] - Short-term borrowings increased to approximately RMB 866.46 million from RMB 824.31 million, an increase of about 5.1%[18] - The company’s long-term investments in non-current financial assets rose significantly to approximately RMB 109.15 million from RMB 10.52 million, an increase of about 936.5%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,866[11] - Wanbangde has committed to invest up to RMB 300 million in a healthcare investment fund, which has a target size of RMB 1 billion[13]